CURRICULUM VITAE

I. PERSONAL DATA:-

NAME Faris Q.B. Alenzi Date of birth 20th October, 1971 Place of birth Riyadh, Saudi ArabiaNationality SAUDI ARABIANMarital status MarriedEmail faris_alenzi@hotmail.com

fqalenzi@ksu.edu.sa f.alenzi@psau.edu.sa

Work Address Department of Medical Laboratories College of Applied Medical Sciences Prince Sattam bin Abdulaziz University (Al-Kharj)PO Box 422 Al-Kharj 11942 SAUDI ARABIA

Website https://faculty.psau.edu.sa/f.alenzi

II. ACADEMIC QUALIFICATIONS:-

S/N ACADEMIC DEGREE

PLACE OF ISSUE MAJOR DATE

1. Consultant Saudi Council for Health Specialties Immunology 2006

2. Ph.D. Imperial College, School of Medicine, University of London, U.K.

Immunology 2003

3. M.Sc. Imperial College, School of Medicine, University of London, U.K.

Immunology 1999

4. B.Sc. College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia

Med. Lab. Sciences

1996

1

III. EMPLOYMENT RECORD:-S/N JOB RANK PLACE AND ADDRESS OF WORK DATE1. Professor of Immunology Department of Medical Laboratory

Sciences, College of Applied Medical Sciences, Salman bin Abdulaziz University (Al-Kharj), Saudi Arabia

Jan 2012 – Now

2. Associate Professor of Immunology

Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Salman bin Abdulaziz University (Al-Kharj), Saudi Arabia

Nov 2007 Dec 2011

3. Assistant Professor of Immunology

Department of Medical Laboratory Sciences, College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

2003-2007

IV. POSITIONS HELD

S/N JOB RANK PLACE AND ADDRESS OF WORK

DATE

1. Dean College of Applied Medical Sciences, Al-Kharj University, Saudi Arabia

2007-2008

2. Vice Dean for Training College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

2005-2006

3. Laboratory Director Dar Shefa Hospital, Riyadh Saudi Arabia

2015-Now

4. Consultant Immunologist and Serology Laboratory Supervisor

Serology Lab Supervisor, Saad Specialist Hospital, Al-Khobar, Saudi Arabia

July-August 2004

5. Member of Deans’ Council King Saud UniversitySaudi Arabia

2007-2009

6. Member of Dept Board Dept of Med Lab Sci 2003-Now

2

V. MEMBERSHIP OF PROFESSIONAL SOCIETIES1. Founder, the Saudi Society for Cell Death (PSAU - 2017)2. Founder, the Saudi Society for Immunology and Asthma (KSU - 2008)3. Founder, Charity of Balasm Shefa (health) for drug distribution (2017)4. Founder, Charity of Fekr (Think) (2017)5. Member of Saudi Society of Microbiology and Infectious Diseases6. Member of American Society of Experimental Biology and Medicine7. Member of American Society of Hematology8. Member of American Academy of Allergy, Asthma, and Immunology9. Member of American Association of Immunologists10. Member of American Society for Microbiology11. Member of American Society of Clinical Pathologists12. Member of International Society of Cell Death13. Member of International Society of Experimental Hematology14. Member of European Academy of Allergy and Clinical Immunology15. Member of British Society of Immunology16. Member of IBMS, London, UK

VI. PUBLICATIONS

S/N NAME OF INVESTIGATOR(S)

ARTICLE TITLE PUBLISHER AND DATE OF

PUBLICATION1. Menyfah Alanazi, and

Faris Alenzi An Evaluation of community acquired urinary tract infection and appropriateness treatment in Emergency Department at King Abdulaziz Medical City in Saudi Arabia

Submitted

2. Menyfah Alanazi, and Faris Alenzi

An Evaluation of E.coli in urinary tract infection in Emergency Department at King Abdulaziz Medical City in Saudi Arabia

Submitted

3. Muslih Alotaibi… Faris Alenzi

Clinical utility of urine to measure LH and FSH

Submitted

4. Faris Alenzi and Iman El-Nashar.

Role of Stem cell in Experimentally Induced Diabetes Mellitus

Submitted

3

5. Faris Alenzi and Iman El-Nashar.

Role of stem cells in encephalo-myelitis and brain damage

Submitted

6. Faris Alenzi et al. Fine Needle Aspiration Cytopathology of Pediatric Lymphadenopathy among Saudi Children

Article In Preparation

7. Faris Alenzi et al. Seroprevalence of Toxoplasma Gondii Among Pregnant Women Attending Maternity Hospital in Riyadh, KSA

Article In Preparation

8. Faris Alenzi et al. Evaluation of Biochemical and Hematological Markers of Cerebrospinal Fluid in Suspected Patients with Meningitis

Article In Preparation

S/N NAME OF AUTHORS TITLE PUBLISHER AND DATE OF

PUBLICATION1. Lulu A Albhlal, Fahd G Alanzi,

Khalid Bin Ghannam, Alwaleed Alqahtani, Ayisha Q Alenazi, Meaad Q Alanazi, Abdulrahman Q Alanazi, Faris Q Alenzi

Sleep Disturbance Patterns among Medical Students, Saudi Arabia

Archives of Medicine 2017; 09(03);10-17

2. Faris Q Alenzi Talat A Al bukhari, Mohamed W Al Rabea, Reda G Alenazi, Wail O Alenizy

The expression of BCL-G in leukemia and gastrointestinal tissues

Bangladesh Journal of Medical Science Vol.16(3) 2017 p.433-438

3. MW Al Rabea, MA Al Nafea, WG Tamimi, Faris Q Alenzi

Role of T Lymphocytes In Chronic Leukemia

Bangladesh Journal of Medical Science Vol.16(2) 2017 p.207-211

4. Faris Q Alenzi Signal Transduction Pathway in Chronic Leukemia

Bangladesh Journal of Medical Science Vol.16(1) 2017 p.21-23

5.Hussein AM, Sakr HF, Alenzi FQ . Possible Underlying Mechanisms of the

Renoprotective Effect of Remote Limb Ischemic Preconditioning Against Renal Ischemia/Reperfusion Injury: A Role of Osteopontin, Transforming Growth Factor-Beta and Survivin

Nephron. 2016;134(2):117-129.

6. Zekri AR, Youssef AS, Lotfy MM, Gabr R, Ahmed OS, Nassar A, Hussein N, Omran D, Medhat E, Eid S, Hussein MM, Ismail MY, Alenzi FQ , Bahnassy AA.

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.

PLoS One. 2016 May 2;11(5):e0154130. doi: 10.1371

7. Al-Rabea MW, Alanazi A, Al-Shaya DS, Ayoubi DA, Al-Minsour FA, Mansour O, Zekri ARN, Al-Momen AM,

AlMurshid EM,Wyse RK and

Chronic Myeloid Leukemia : an Update in cells, genes and molecules

Review Article, Prensa Med Argent 2015; 102, 1

4

Alenzi FQ8. Tamader Al Doheyan, Ala’a Al

Saad, Adwa Al Haidar, Haifa Al Fwzan, Jawaher Al Askar, Faisal Al Malki, Omar H. A. Alanzi, Mona Q. Alanazi, Wafa Q. Alanazi, Jawhra Q. Alanazi, Fahad G. Alanazi, Omar Baqadir, Abdul Rahman Q. Alanazi, Abdul Majeed Q. Alanazi and Faris Q. Alenzi

Knowledge, Attitude and Practices Concerning Cosmetic Surgery among Female Medical Students at the University Hospital, King Saud University, Riyadh, Saudi Arabia

British Journal of Medicine and Medical Research: 2016, 14, 1-10

9. Faris Q AlenziVirulence factors of Candida species isolated from patients with urinary tract infection and obstructive uropathy

Pak J Med Sci. 2016 Jan-Feb; 32(1): 143–146.

10. Faris Alenzi The significance and occurrence of TNF receptor polymorphisms in the Saudi population

Saudi J Biol Sci, 2016; Volume 23 , 767-772

11. Waleed Tamimi, S Aljasser, R Kanan… Faris Q Alenzi and R Hasanato.

Effects of Hemoglobin Variants on Hemoglobin A1c Values Measured Using a High-Performance Liquid Chromatography Method

J Diabetes Sci Technol. 2014 Nov; 8(6): 1168–

1176.

12. Faris Q Alenzi, Ahmed Q. Alotaibi, Gdhi M. Almotiri, Anwar M. Alanazi, Faisal M. Alanazi, Mohammed S. Alenazi, Khalaf A. Alanazi, Mohammed J. Alenzi, Shamweel Y. Ahmad

Role of Apoptosis in Microbial Infection Open Journal of ApoptosisVol.3 No.2(2014), Article ID:45380,7 pages

13. Bassel Tarakji, Mohammed Alsakran Altamimi, Kusai Baroudi, Mohammad Z Nassain, and Faris Q Alenzi

Immunohistochemical expression of p16 in Carcinoma Ex-pleomorphic Adenoma (undifferentiated and Adenocarcinoma Types)

J Clin Diagn Res. 2013 Dec; 7(12): 3054–3056.

14. Tarakji B, Alenzi FQ, Al-Khuraif AA

Assessment of inverse correlation of p16 and pRb expression in carcinoma ex pleomorphic adenoma.

Pol J Pathol. 2013;64(2):144-8 .

15. Al-Maneea M, Al-Juhaim S, Al-Hatlan O, Kujan O, Tarakji B, Azzegahiby S, Azzegahiby I, Wyse RK, Al-Rabia MW, Alenzi   FQ.

Animal allergy among husbandry personnel in Riyadh.

J Ayub Med Coll Abbottabad. 2013 Jan-Jun;25(1-2):133-5.

16. Al-Ghonaim AS, Al-Qassam SR, Kujan O, Tarakji B, Azzegahiby S, Azzegahiby I, Wyse RK, Al-Rabia MW, Alenzi   FQ.

Prevalence of wheat allergy in Al-Kharj, Saudi Arabia.

J Ayub Med Coll Abbottabad. 2013 Jan-Jun;25(1-2):52-6.

17. Faris Alenzi, and Richard K.H.Wyse.

THE ROLE OF EOSINOPHILS IN ASTHMA(REVIEW)

Journal of Health. Vol.5 No.2A, February 2013; 339-343

18. Faris Alenzi, Fahad G. B. Alanazi, Shamweel Ahmed,

Antioxidant Properties of Nigella Sativa.(REVIEW)

Journal of Genetics and Molecular Medicine; Sept 2013;7;3

5

Waleed Tamimi, Hamdan Alshehri, Mahmoud Lotfy, and Mohamed L. Salem.

19. Kujan O, Abuderman A, Azzegahiby S, Alenzi FQ, Idrees M.

Assessing Oral Cancer Knowledge Among Saudi Medical Undergraduates

Journal of Cancer Education2013, Volume 28,  717–721

20. Tamimi W, Martin-Ballesteros J, Brearton S, Alenzi FQ, Hasanato R.

Evaluation of biological specimen acceptability in a complex clinical laboratory before and after implementing automated grading serum indices.

Br J Biomed Sci. 2012;69(3):103-7.

21. Faris Alenzi, Fadad G. B. Alanazi, Omar Kujan, Bassel Tarakji, Waleed Tamimi , Ayed Alanazi and Richard K.H. Wyse

Ethical and socio-political status of stem cell research in Saudi Arabia.(REVIEW)

Journal of Cell Science & Therapy, 2012, 3:7

22. Faris Alenzi, Ali M. Al-Amri, Fahad G. B. Alanazi, Waleed Tamimi, Ayad AlanaziAwwad K. Alenezy, Farhan Al Swailmi

CELLULAR AND MOLECULAR RESPONSES OF SAUDI CML PATIENTS TO IMATINIB (STI571); TEN YEAR EXPERIENCE.

J Ayub Med Coll Abbottabad. 2012 Apr-Jun;24(2):122-8.

23. Faris Alenzi, Fadad G. B. Alanazi, Fadel S. Alyaqoub, Waleed Tamimi, Hamdan Alshehri and Mohamed L. Salem.

Apoptotic Proteins and Cancer: Many Faces.(REVIEW)

J Ayub Med Coll Abbottabad. 2012 Jan-Mar;24(1):111-5.

24. Faris Alenzi Is there a Link between Apoptosis and Chronic Leukemia?(REVIEW

Journal of Cell Science & Therapy 2012, 3, p1

25. Faris Alenzi CELLULAR AND MOLECULAR ASPECTS OF THE GOODPASTURE'S SYNDROME (REVIEW)

Iran J Kidney Dis. 2012 Jan;6(1):1-8.

26. FARIS ALENZI, FAWWAZ A. ALENAZI, YAHIA AL-KAABI AND MOHAMED L. SALEM.

The use of growth factors to modulate the activities of antigen–specific CD8+ T cells in vitro

J Med Life. 2011 Nov 14; 4(4): 399–406.

27. M. L. SALEMF. Q. ALENZI and W. Y. ATTIA

Thymoquinone, the active ingredient of Nigella sativa seeds, enhances survival and activity of antigenspecific CD8-positive T cells in vitro

BRITISH JOURNAL OF BIOMEDICAL SCIENCE 2011 68 (3) 131-137

28. Faris Alenzi, Mahmoud Lotfy, Wasam Nasif, Mohamed El-Shahat, Hasan Abusini, Mohamed Alenazi, Fawwaz A Alenazi, Waleed G Tamimi, Mohamed L Salem

Biomedical research in the Middle Eastern countries: update and insight using SCImago Journal Rank indicator.

J Ayub Med Coll Abbottabad. 2010 Jul-Sep;22(3):100-5.

29. Alenzi FQ, El-Nashar EM, Al-Ghamdi SS, Abbas MY, Hmad AM, El-Saeed OM, Wyse RK, Lotfy M.

Investigation of Bcl-2 and PCNA in Hepatocellular Carcinoma: Relation to Chronic HCV.

J Egypt Natl Canc Inst. 2010 Mar;22(1):87-94.

30. Alenzi FQ. Cell type specific expression of the apoptosis stimulating protein (ASPP-2) in

Acta Microbiol Immunol Hung. 2010

6

human tissues. Dec;57(4):419-29.

31. Alenzi FQ, Lotfy M, Tamimi WG, Wyse RK.

Stem cells and gene therapy. (REVIEW) Lab Hematol. 2010 Sep;16(3):53-73.

32. Alenzi FQ, Lotfy M, Wyse R. Swords of cell death: caspase activation and regulation. (REVIEW)

Asian Pac J Cancer Prev. 2010;11(2):271-80

33. Alenzi FQ, El-Bolkiny Yel-S, Salem ML.

Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide.

Br J Biomed Sci. 2010;67(1):20-8.

34. Alenzi FQ. H1N1 update review.(REVIEW)

Saudi Med J. 2010 Mar;31(3):235-46.

35. Tamimi W, Alaskar A, Alassiri M, Alsaeed W, Alarifi SA, Alenzi FQ, Jawdat D.

Monoclonal gammopathy in a tertiary referral hospital.

Clin Biochem. 2010 Jun;43(9):709-13.

36. Alenzi FQ, Alenazi B, Alanzy F, Mubaraki A Salem ML, Al-Jabri AA, Richard K.H. Wyse

The role of caspase activation and mitochondrial depolarisation in cultured human apoptotic eosinophils

Saudi Journal of Biological Sciences 2010; 17: 29-36

37. Alenzi FQ, Salem M, Tamimi W, Lotfy M, Al-Ghamdi S, Damanhouri L, Bukhari T, Wyse RK

NKH477 inhibits proliferation and induces apoptosis in a panel of cancer cell lines

Journal of Postgrad Medical Institute 2010, 24: 182-7

38. Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM.

Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.

Saudi Med J. 2009 Nov;30(11):1416-21.

39. Ahmad S, Al-Juaid NF, Alenzi FQ, Mattar EH, Bakheet O.

Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.

J Coll Physicians Surg Pak. 2009 Apr;19(4):264-5.

40. Abusini H, Abuelteen K, Elkarmi A, Alenzi FQ, Lotfy M.

Investigation of Helicobacter pylori infection in Jordanian patients using six enzyme immunoassays for immunoglobulin G (IGG) and IGA testing.

Roum Arch Microbiol Immunol. 2009 Oct-Dec;68(4):240-5.

41. Alenzi FQ, Alenazi B, Ahmad SY, Salem ML, Al-Jabri AA, Wyse RK.

The haemopoietic stem cell: between apoptosis and self renewal. (REVIEW)

Yale J Biol Med. 2009 Mar;82(1):7-18.

42. Alenzi FQ. Effect of nicotinamide on experimental induced diabetes.

Iran J Allergy Asthma Immunol. 2009 Mar;8(1):11-8.

43. Al-Jabri A & Alenzi FQ. Vaccines, virucides and drugs against HIV/AIDS: hopes and optimisms for the future. (REVIEW)

Open AIDS J. 2009;3:1-3.

44. Lotfy M, Badi Alenazi, Shamweel Ahmed, Waleed Tamimi, Mohamed Salem, Richard KH Wyse, Faris Q. Alenzi.

Programmed cell death of B lymphocytes is induced by ligation of integrin-associated protein (CD47)

The New Egyptian Journal of Medicine2009, 41: 18-27

45. Alenzi FQ. The role of apoptotic proteins in patients with systemic lupus erythematosis.

Egypt J Immunol. 2009;16(1):107-16.

46.Alenzi FQ, Al-Rabia MW, Alenazi BQ, El-Nashar I, Mubaraki AM, Al-Anazy FH, Tamimi WG, Salem ML, Wyse

Modulation of dendritic cell activation chemokines and cellular injury.

Egypt J Immunol. 2009;16(1):71-81.

7

R

47. Faris Q Alenzi, Mohammed W Al-Rabia, Badi Q Alenazi, Mohamed Labib Salem, Haris M Siddiqui, Jamal M Arif, Richard K Wyse

Role of CTLA-4 in Xenotransplantation. (REVIEW)

Pak J Physiol 2009;5(2): 40-5

48. Al-Jabri A.A., Al-Muharrami Z, Balkhair A, Alenzi FQ, BaOmar AA

Overview of factors affecting AIDS progression (REVIEW)

International J Med and Biol Frontiers 2009; 16:issue ¾, pp. 211-236.

49. Alenzi FQ. Role of apoptosis in airway epithelium Pak J Physiol 2009;5(1): 1-10

50. Mohamed Labib Salem, Faris Alenzi, Amir A. Al-Khami, Ali A. Richard K.H. Wyse

Plasticity of T cell differentiation and cytokine signature: A double-edged sword for immune responses.(REVIEW)

Immun., Endoc. & Metab. Agents in Med. Chem., 2009, 9, 90-105

51. Mohamed L. Salem, Faris Q. Alenzi, Iman M. El- Nashar, Iman El-Tounsi, Richard Wyse

Teaching versus research dilemma in academia: A Literature review(REVIEW)

The BioMed Scientist 2009, Vol. 5,: 6-9.

52. Alenzi FQ. BCL-6 prevents mammary epithelial apoptosis and promotes cell survival.

J Pak Med Assoc. 2008 Sep;58(9):494-7.

53. Alenzi FQ. Apoptosis and eosinophils. Regulation and clinical relevance. (REVIEW)

Saudi Med J. 2008 May;29(5):643-56.

54. Alenzi FQ. Detection of IgG anti-beta2 glycoprotein-I antibodies in Saudi patients with systemic lupus erythematosis.

Saudi Med J. 2008 Apr;29(4):594-9.

55. Alenzi FQ. Epithelial cells protect T cells from apoptosis

Indian Journal of Allergy, Asthma, and Immunology, 2008, 22: 73-83

56. ElTounsi E, Alenzi FQ. Study of some deletion mechanism for multidrug resistant P-gp and mRNA in AML and correlation to clinical outcome

The New Egyptian Journal of Medicine2008: 38 (1): 26-33

57. ElTounsi E, Alenzi FQ. Increased expression of survivin in TNF-related apoptosis inducing ligand (TRAIL) resistant AML

Egyptian Journal of Hematology, 2007; 32 (3): 147-158

58. ElTounsi E, Alenzi FQ. TOSO, an alternative resistance mechanism to Fas induction of apoptosis in AML

Egyptian Journal of Hematology, 2007; 32 (3): 213-228

59. Badra G, El-Abassy M, Lotfy M, Alenzi FQ Waked I.

A life-sustaining single dose of recombinant activated factor VII for an Egyptian patient with hemorrhagic crisis.

Saudi Med J. 2007 Jun;28(6):979-81

60. Alenzi FQ, Wyse RK, Tamimi WG, Bamaga MS, Lotfy M.

A close link between Fas, p53 and Apaf-1 in chronic myeloid leukemia.

Saudi Med J. 2007 Jul;28(7):1119-21

61. Lotfy M, Badra G, Burham W, Alenzi FQ.

Combined bee honey, bee propolis and myrrh for favorable healing of a deep infective wound in patient with diabetes mellitus

Br J Biomed Sci; 2006;63(4):171-3

62. Alqahatani M, Tamimi W, Aldaker M, Alenzi FQ, Tamim H, Alsadhan A.

Young adult reference ranges for thyroid function tests on the Centaur immunoassay analyser.

Br J Biomed Sci; 2006;63(4):163-5.

63. Alenzi FQ. Cytokines and soluble ICAM-1 in serum of eczematous children

Allergy and Asthma Proceedings; 2006 Mar-Apr;27(2) :126-9.

64. Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M,

Nucleic acid amplification technology screening for hepatitis C virus and human

Saudi Med J.; 2006 Jun;27(6):781-7

8

Alenzi FQ. immunodeficiency virus for blood donations.

65. Alenzi FQ. Apoptosis and Diseases; Regulation and Clinical Relevance(REVIEW)

Saudi Med J.; 2005 Nov;26(11):1679-90

66. Alenzi FQ, Al-Ghamdi SM, Tamimi WG, Al-Sebiany AM, El-Nashar IM, El-Tounsi I, Bamaga MS, Al-Enazi M.

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.

Yale Journal of Biology and Medicine; 2005 Jan;78(1):25-36

67. Alenzi FQ. Autoimmune haemolytic anemia is associated with a defect in Fas-mediated apoptosis

Br J Biomed Sci; 2004;61(2):96-8

68. Alenzi FQ. Induction of apoptosis in myeloid progenitors by granulocyte-macrophage colony-stimulating factor (GM-CSF)

Br J Biomed Sci; 2004;61(4):200-5.

69. Tamimi WG, Altraif IM, Auumah A, Albuharian BS, Alenzi FQ, Bernvil S, Sonbol RH, Cruse RJ.

The impact of the AABB regulations on hepatitis B and C testing among Saudi Blood Donors

Br J Biomed Sci; 2004;61(4):215-7.

70. Alenzi FQ, Wyse RK, Altamimi WG.

Apoptosis as a therapeutic tool for hematological malignancies (REVIEW)

Expert Opinion in Biological Therapy; 2004 Mar;4(3):407-20

71. Alenzi FQ. Links between apoptosis, cell cycle and proliferation (REVIEW)

Br J Biomed Sci; 2004;61(2):99-102

72. Alenzi FQ, Warrens AN Cellular and molecular themes of apoptosis (REVIEW)

The Middle European Journal of Medicine;2003 Sep 15;115: 563-74

73. Alenzi FQ, Marley S, Chandrashekran A, Botto M, Warrens A, Goldman J.

Regulation of haemopoietic progenitor cell number by the Fas/FasL apoptotic mechanism

Exp Hematology; 2002 Dec;30(12): 1428-35

74. Marley SB, Lewis JL, Zheng B, Davidson D, Alenzi FQ, Goldman JM.

Peripheral blood progenitor cell mobilization alters myeloid, but not erythroid progenitor cells self-renewal kinetics

Bone Marrow Transplantation; 2001 Feb;27(3):241-8

9

VII. CONFERENCES ATTENDED

S/N NAME OF CONFERENCE OR

WORKSHOP

DATE AND PLACE TYPE OF PARTICIPATION

1. AAAAI annual conference

3-7 March 2016LA, USA

Poster Presenter

2. Immunotherapy of hematological malignancies

20 Aug- 24Aug 2015 Vermont, USA

Attended

3. Role of Cell death in immunity and cancer

28 oct-2 Nov 2014 Sao Paolo, Barzil,

Attended

4. The Annual Congress of AMLI, GA, USA

10-14 Aug 2013 Savannha, GA, USA

Poster Presenter

5. Stem cell Conference, Frankfurt

Colon, Germany March 6-9, 2012,

Speaker

6. ArabLab Feb 2011 Dubai, UAE

Attended

7. The Annual Congress of AMLI, CA, USA

13-16 Aug 2011San Diago, CA, USA

Speaker

8. Learning and Teaching workshop

8-12 Aug 2011Vancouver, Canada

Attended

9. Annual Conference of British Society for Immunology

Nov 2010 Liverpool, UK

Attended

10. International Congress in antibodies

2009Beijing, China

Speaker

11. International Congress in Asthma and Allergy

2009 Dubai, UAE

Poster Presenter

12. Australian Soc. For Immunology

Feb 2009Queensland, Australia

Poster Presenter

13. Cytokine and Inflammation

Oct 2009 Lisbon, Portugal

Poster Presenter

14. Apoptosis Meeting June 2009Johannesburg, South Africa

Poster Presenter

15. International Innovation Conference

March 2009KL, Malaysia

Poster Presenter

16. Cell Death Meeting July 2008Ulm, Germany

Attended

17. The Cancer Immunology Meeting

2nd -6th Dec 2008Miami, FL, USA

Attended

10

18. The Annual Conference of British Society for Immunology

15th -21st Nov 2008Glasgow, U.K.

Poster Presenter

19. The 19th Conference of Saudi Heart Association

11th-15th Feb 2008, National Guard Hospital, Riyadh, Saudi Arabia

Attended

20. 2nd Annual Conference of Saudi Society of Microbiology Infectious Diseases

19th-21st Jan 2008, National Guard Hospital, Riyadh, Saudi Arabia

Attended

21. Avian Influenza Day 5th Jan 2008, National Guard Hospital, Riyadh, Saudi Arabia

Attended

22. Current concepts and Issues in Pathology and Laboratory Medicine

19th-21st Nov 2007, National Guard Hospital, Riyadh, Saudi Arabia

Attended

23. The 20th Annual Conference of American Association of Medical Lab. Immunologists

9th-13th Aug 2007, Chicago, IL, USA Poster Presenter

24. The First Research on Apoptosis

8th November 2006, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Organizer and Speaker

25. Infection Control in the College Laboratories.

12th-13th September 2006, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

26. Problem-based learning (PBL).

5th September 2006, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

27. How to use e-Learning effectively.

4th September 2006, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

28. Exam blueprint utilization for applied health college.

3rd September 2006, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

29. Student portfolio 2nd September 2006, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

30. American Association of Immunologists Conference

11th-16th May 2006, at Boston, MA, USA

Attended

31. Paediatric Respiratory Care & 1st Saudi Respiratory Society Meeting

1st December 2005, at the King Fahad University Hospital, Dammam, Saudi Arabia

Attended

32. Molecular Diagnostics Group (MDG) 2nd International Conference

5th-7th December 2005, at Jeddah, Saudi Arabia

Speaker

11

33. International Heart Day September 2005, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Organizer and Speaker

34. The Conference of Medical Laboratory Technology: Future and Expectation.

26th-27th April 2005, at the King Fahad University Hospital, Dammam, Saudi Arabia

Speaker

35. The First Molecular Medicine Day

25th April 2005, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Organizer and Speaker

36. How to prepare the MCQs

1st March 2005, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

37. The monthly meeting of the Saudi Hematology, Oncology Eastern Club

18th December 2004, at the Dhahran Hotel, Saudi Arabia

Speaker

38. Eighth Conference of the Saudi GIT Society

November 2004, at the King Fahad University Hospital, Dammam, Saudi Arabia

Speaker

39. Lecturing Skills Workshop

12th October 2004, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

40. 12th Immunology Conference

July 2004, at Montreal, Canada Poster Presenter

41. The Effective Use of Audiovisual Aids. Effective Teaching Workshop

April 2004, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Attended

42. Breast Update Conference March 2004 at the King Fahad University Hospital, Dammam, Saudi Arabia

Speaker

43. Workshop on Safety 4th September 2005, at the College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia

Speaker

44. Molecular Biology of Haemolytic Anemia

December 2003, at the King Fahad University Hospital, Dammam, Saudi Arabia

Attended

45. Molecular Applications in Medicine

6th-8th October 2003, at Jeddah, Saudi Arabia

Attended

46. Innate Mechanism of epithelial host defense

20th September 2002, at London, U.K Attended

47. The 4th Annual conference of Saudi Medical Technologists

1st September 2001, at London, U.K Organizer and Speaker

48. Basic and Clinical Allergy Course

April 2001, at the National Institute for Heart and Lung, London, U.K

Attended

12

49. Signal Transduction in chronic inflammation

11th December 2000, at London, U.K Attended

50. One Day in an Intracellular Staining

September 2000, at London, U.K Attended

VIII. GRANTS AND AWARDS:

S/N TITLE OF THE AWARD AMOUNT DATE1. Research Grant from the Sattam Univ (PSAU), al-kharj

To establish “Leukemia Research Unit”$160,000 2016

2. Research Grant from the Sattam Univ (PSAU), al-kharjTo establish “International Collaboration Program”

$50,000 2014

3. Research Grant from the NPST, KACST, Riyadh“Herbs in Medicine from Saudi Environment”

$540,000 2013

4. Research Grant from the NPST, KACST, Riyadh“Therapeutic applications of Stem Cells”

$540,000 2010

5. Research Grant from the KACST, Riyadh, KSA“Apoptosis Role in Leukemia”

$160,000 2006

6. Research Grant from the KFU, Dammam, KSA“Role of CD25CD4 in Leukemia”

$50,000 2004

7. British Journal of Hematology award, London, UK $1000 2000

8. Leukemia Research Fund award, London, UK $500 2000

9. King Salman Award for Excellence in Sciences, Riyadh, SA

Medal & Certificate$500

1988

IX. CLINICAL & RESEARCH ATTACHMENT :

S/N POST PLACE DATE1. Visiting Faculty Hillman Cancer Center, College of

Medicine, University of Pittsburgh, PA, USA.

Aug 2014

2. Visiting Faculty Department of Laboratory Medicine, College of Medicine, University of Pittsburgh, PA, USA.

Aug 2013

3. Visiting Faculty HLA and Flow Lab, Department of Pathology, College of Medicine, University of Florida, Florida, USA .

July 2006

13

4. Visiting Faculty Immunopathology Unit, Pathology andLaboratory Medicine Department, at theKFSHRC, Riyadh, KSA

July 2005

X. TEACHING EXPERIENCES/N TITLE OF THE COURSE CREDIT

HOURSLEVEL

1. Pathology 2 3rd Level

2. Hematology 3 4th Level

3. Basic Immunology 3 5th Level

4. Clinical Immunology & Serology 2 7th Level

5. Blood Banking 4 7th Level

6. Laboratory Administration & Safety 2 9th Level

7. Research Graduation Project 2 9th Level

XI. PROFESSIONAL ACTIVITIES1. Administrative duties & Committee membership:

S/N YEAR DESCRIPTION1. 2016-Now Member, University’s Distinction Committee

Salman bin Abdulaziz University (Al-Kharj), Saudi Arabia2. 2015-Now Secretary & Member of College’s community committee,

College of Applied Medical Sciences, Salman bin Abdulaziz University (Al-Kharj), Saudi Arabia

3. 2012-Now Member, University’s Collaboration CommitteeSalman bin Abdulaziz University (Al-Kharj), Saudi Arabia

4. 2010- Now Member, College’s Developmental committeeCollege of Applied Medical Sciences, Salman bin Abdulaziz University (Al-Kharj), Saudi Arabia

5. 2013- Now Member, College’s Recruitment committeeCollege of Applied Medical Sciences,

14

Salman bin Abdulaziz University (Al-Kharj), Saudi Arabia6. 2010- Now Secretary & Member of College’s monthly seminars

workshop committee, College of Applied Medical Sciences, Salman bin Abdulaziz University (Al-Kharj), Saudi Arabia

7. 2004-2007 Coordinator of the College’s monthly seminars, College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia.

8. 2004-2007 Member of the Safety Committee, College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia.

9. 2004-2007 Secretary & Member of the Curriculum Committee,College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia.

10. 2006-2007 College Representative for the documentary film preparedby ARA Company, College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia.

11. 2005-2007 College Representative for the Library Deanship, College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia.

12. 2005-2006 Supervisor of the College electronic website, College of Applied Medical Sciences, King Faisal University, Dammam, Saudi Arabia.

15

2. Community Services:

1. An inventor; Saudi Patent Office, submitted 2015; on methods to optimize the biological activity of recombinant growth factors that mobilize hematopoietic stem cells from bone marrow in cancer patients after chemotherapy.

2. I am an author of Three Books in Immunology (In Arabic - in press).

3. I am a co-Author of Fundamentals of Cancer biology (In English - in press).

4. Conference Organization: Organizer, Immunology & Cancer Workshop, march 2016, PSAU, Al-Kharj Organizer, International Asthma Day, March 2014, PSAU, Al-Kharj , SA

Organizer, Avian Flu workshop, 2008, Al-Kharj, SAOrganizer, First Research on Apoptosis, 2006, Dammam, SA

Organizer, International Heart Day, 2005, Dammam, SA Organizer, First Molecular Medicine Day, 2005, Dammam, SA Member Org Com, Conference of Med. Lab. Tech., 2005, Dammam, SA Member Org Com, Workshop on Safety, 2005, Dammam, SA

5. Journals:

- Founding Editor of the “ Saudi Journal of Applied Sciences” under Princess Noura University, Riyadh, SA (2016)

- Editor for British Journal of Medicine and Medical Research (2014-Now)

Regular reviewer for the following journals: Saudi Medical Journal, Annals of Saudi Medicine, Afr J Biotech, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry& Journal of Cell Science & Therapy and International Journal of Medicine and Medical Sciences.

16

6. TV guest speaker in several sessions and writer many articles in daily newspapers and electronic scientific sites, and Reviewer for the KACST applications.

17